Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol add-on for pain in advanced cancer patients on opioids
ACTRN12610000893000Phase 4Not yet recruiting
- Sponsor
- The University of Queensland
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cancer pain comparing Paracetamol first sequence with Placebo first sequence (2 arms). Primary endpoint: Average pain score. Planned start Nov 2010; status: not yet recruiting.
02
Drugs
acetaminophen
03
Conditions
cancer pain
Beyond the preview
Go deeper on ACTRN12610000893000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000893000.